Constituents with DNA Topoisomerases I and II Inhibitory Activity and Cytotoxicity from the Roots of Rubia cordifolia

Abstract

Activity-directed isolation of the ethyl acetate fraction from the roots of Rubia cordifolia resulted in the identification of a new anthraquinone, 1,3,6-trihydroxy-2-hydroxymethyl-9,10-anthraquinone-3-O-α-L-rhamnopyranosyl-(1 → 2)-β-D-(6′-O-acetyl)-glucopyranoside (1), two new dihydronaphtoquinones, 1,4-dihydroxy-2-carbomethoxy-3-prenylnaphthalene-1-O-β-D-glucopyranoside (2) and mollugin-1-O-β-D-glucopyranoside (3), and a new monoterpenoid, 3R,3aS,4R,6aR-3,4,6-tris(hydroxymethyl)-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2-one (4), together with nine known compounds (5–13). The structures of these compounds were elucidated on the basis of spectroscopic evidence. In addition, their DNA topoisomerases I and II inhibitory activity and cytotoxicity were measured.

Rubia cordifolia - Rubiaceae - DNA topoisomerases I and II inhibitory activity - cytotoxicity

References

• 1 Lee C B. Coloured flora of Korea. Seoul: Hyang Mun Sa; 1999: 696
• 2 Song L R, Hong X, Ding X L. Modern dictionary of Chinese materia medica [M]. 1st edition. Beijing: People's Health Publishing House; 2001: 1463-1466
• 3 Chung M I, Jou S J, Cheung T H, Lin C N. Antiplatelet constituents of Formosan Rubia akane.  J Nat Prod. 1994;  57 313-316
• 4 Han B H, Park M K, Cheng T H, Lin C N. A lignan from Rubia akane.  Arch Pharm Res. 1990;  13 289-291
• 5 Itokawa H, Mihara K, Takeya K. Studies on a novel anthraquinone and its glycosides isolated from Rubia cordifolia and R. akane.  Chem Pharm Bull. 1983;  31 2353-2358
• 6 Son J K, Jung J H, Lee C S, Moon D C, Choi S W, Min B S, Woo M H. DNA topoisomerases I and II inhibition and cytotoxicity of constituents from the roots of Rubia cordifolia.  Bull Korean Chem Soc. 2006;  27 1231-1234
• 7 Son J K, Jung S J, Fang Z, Lee C S, Seo C S, Moon D C, Min B S, Kim M R, Woo M H. Anticancer constituents from the roots of Rubia cordifolia.  Chem Pharm Bull. 2008;  56 213-216
• 8 Itokawa H, Quao Y, Takeya K. Anthraquinones and naphthohydroquinones from Rubia cordifolia.  Phytochemistry. 1989;  28 3465-3468
• 9 Courchesne M, Brassard P. Identification and characterization of naturally occurring rubiadins.  J Nat Prod. 1993;  56 722-730
• 10 Chen B Z, Chen S B, Dong X. A study on the medicinal plants of genus Rubia. II. Determination of anthraquinone constituents.  Nat Prod Res Dev. 1992;  4 5-10
• 11 Mufti V V S, Seshadri T R, Sivakumaran S. Anthraquinones of Rubia cordifolia.  Phytochem Rep. 1972;  11 1524
• 12 Liu Y L, Chen B Z, Bai Y L, Duddeck H, Hiegemann M. Digiferruginol glycoside from the roots of Rubia schumanniana.  Phytochemistry. 1991;  30 947-949
• 13 Koyama J, Morita I, Kobayashi N, Osakai T, Hotta H, Takayasu J, Nishino H, Tokuda H. Correlation of redox potentials and inhibitory effects on epstein-barr virus activation of naphthoquinones.  Cancer Lett. 2003;  201 25-30
• 14 Itokawa H, Qiao Y, Mihara K, Takeya K. Anthraquinones, naphthoquinones and naphthohydroquinones from Rubia oncotricha.  Phytochemistry. 1991;  30 637-640
• 15 Wang Z T, Xu G J, Hattori M, Namba T. Constituents of the roots of Codonopsis pilosula.  Shoyakugaku Zasshi. 1988;  42 339-342
• 16 Takeda Y, Shimidzu H, Mizuno K, Inouchi S, Masuda T, Hirata E, Shinzato T, Aramoto M, Otsuka H. An iridoid glucoside dimer and a non-glycosidic iridoid from the leaves of Lasianthus wallichii.  Chem Pharm Bull. 2002;  50 1395-1397
• 17 Jennings J P, Klyne W, Scopes P M. Optical rotatory dispersion. Part XXIV. Lactones.  J Chem Soc. 1965;  7211-7229
• 18 Fukuda M, Nishio K, Kanzawa H, Ogasawa H, Ishida T, Arioka H, Bojamowk K, Oka M, Sajio N. Synergism between cisplatin and topoisomerase I inhibitors, NB-506 and SN-38, in human small cell lung cancer cells.  Cancer Res. 1996;  56 789-793
• 19 Rubinstein L V, Shoemaker R H, Boyd M R. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.  J Natl Cancer. 1990;  82 1113-1118